Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1128 Carcinoma, Non-Small-Cell Lung 718 Neoplasms 545 Prostatic Neoplasms 502 Colorectal Neoplasms 438 Multiple Myeloma 336 Lung Neoplasms 309 Neoplasm Metastasis 288 Leukemia, Myeloid, Acute 263 Stomach Neoplasms 248 Carcinoma, Hepatocellular 245 Ovarian Neoplasms 225 Rectal Neoplasms 211 Colonic Neoplasms 204 Lymphoma, Follicular 200 Lymphoma 199 Leukemia 190 Uterine Cervical Neoplasms 181 Head and Neck Neoplasms 174 Pancreatic Neoplasms 171 Lymphoma, Non-Hodgkin 167 Leukemia, Lymphocytic, Chronic, B-Cell 166 Lymphoma, Large B-Cell, Diffuse 163 Recurrence 161 Melanoma 158 Precursor Cell Lymphoblastic Leukemia-Lymphoma 154 Squamous Cell Carcinoma of Head and Neck 147 Pain 141 Urinary Bladder Neoplasms 139 Brain Neoplasms 133

Interventions

pyrotinib 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Interventional × Non-squamous NSCLC × Clear all

NCT04447118 2025-12-19

PYRAMID-1

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Completed

Non-squamous NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡